Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma
Dave Ricks, the CEO of Eli Lilly, the world's most valuable pharmaceutical company, sits down with John and Patrick to discuss the complex business of drug development. Dave explains the true origin story of GLP-1s (from Gila monster saliva), why their potential goes far beyond weight loss to addiction and…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Cheeky Pint
See all episodes →
Similar episodes from other shows
More like Cheeky Pint →
Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing
Why People Are Losing Faith in Healthcare
Anglerfish, Gila Monsters, and the Origin of Weight Loss Drugs
Corner Office Conversation with Eli Lilly's Global CEO David Ricks
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.